Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pain rose during COVID-19 lockdown, Nurofen survey says

Backache, headache and joint pain rose among patients during lockdown, a survey commissioned by Nurofen has found.

The survey revealed that 36% of respondents reported increased backaches since the beginning of lockdown, out of the 2,000 responses that RWB gathered between July 31 and August 3 from people who experienced pain during lockdown.

The survey also indicated that fewer patients were able to speak to their pharmacist after lockdown was imposed, with 17% of respondents saying this, although the figure is five percentage points lower than that for GPs. 

The findings also revealed that 34% of respondents suffered more headaches, followed by 27% who flagged worsened joint pains, while 26% had more neck aches and 24% noted more muscle aches.

Some 60% of respondents wanted more advice on how to manage pain, the survey showed.

For more information on Nurofen products, visit the brand’s website

Have you dispensed many painkillers since the beginning of lockdown?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel